]>
IRCT20180422039378N1 IRCT 2018-06-11 Bagheiat-allah University of Medical Sciences Evaluation of the effect of acetylene drug in comparison with oral administration of pantoprazole in controlling symptoms of gastro-esophageal reflux. Evaluation of the efficacy and safety of stillen in comparison with pentoprazole in controlling the symptoms of gastro-myopic reflux in patients referred to the gastroenterology clinic of Baqiyatallah Hospital 2017-04-19 anticipated 60 Complete https://irct.ir/trial/30804 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to randomization we will use the block method, based on this two lists of patients are provided and each list is placed in one of the groups, Blinding description: This means that patients in groups do not know the used drugs. 3 Gastro-esophageal reflux. Intervention 1: Intervention group: In this group, pantoprazole 40 mg before breakfast and acetylene 60 mg before bedtime, is used. Intervention 2: Control group: In this group, pantoprazole 40 mg before breakfast, is used. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There are no more information.
public Dr. Hossein Khammat
Sheikh Bahay avenue
Tehran Iran (Islamic Republic of) 8819124812 +98 21 8126 4354 dr.shafighi63@gmail.com Bagheiat-allah University of Medical Sciences scientific Dr. Nasrallah Shafiqi
Sheikh Bahay avenue
Tehran Iran (Islamic Republic of) 8819124812 +98 21 8126 4354 dr.shafighi63@gmail.com Bagheiat-allah University of Medical Sciences Iran (Islamic Republic of) Completion of informed consent form Diagnosis of reflux disease is confirmed by clinical and paraclinical findings. The patient's condition is not life-threatening. Do not participate in another clinical trial at the same time. Do not interact with medication before intervention. Like beta blocker inhibitors and herbal medicines or drugs that are harmful for treatment of reflux, such as theophylline, and others. Age over 18 years No smoking in the past Not pregnancy Failure to enter the plan for patients with psychiatric and veterinary injuries due to pulmonary symptoms 18 years no limit Both The occurrence of severe drug-related symptoms and severe hypersensitivity to drugs that can not be controlled. Signs and symptoms of the patient have worsened during the study. Those patients who have not consumed their medication for more than a week. History of chemical gas and severe pulmonary disease. Pregnant or intending to have a pregnancy Presence and observation of drug interactions K21 Gastro-esophageal reflux disease Treatment - Drugs Treatment - Drugs Intervention group: In this group, pantoprazole 40 mg before breakfast and acetylene 60 mg before bedtime, is used. Control group: In this group, pantoprazole 40 mg before breakfast, is used. Symptoms of Gastro-esophageal reflux Disease. Timepoint: Before starting treatment, as well as at 3 and 6 weeks after starting treatment. Method of measurement: Interview with patients using reflux symptom index questionnaire. Bagheiat-allah University of Medical Sciences Approved 2017-04-09 Ethics committee of Baqiyatallah University of Medical Sciences Vanak Square, Mulla Sadra St. Tehran Tehran Iran (Islamic Republic of)